GLP-1 Weight Loss Drugs Explained: Ozempic’s Benefits & Risks
Exploring the Mechanistic Sophistication of GLP-1 Agonists in Weight Management GLP-1 receptor agonists, such as Ozempic (semaglutide), represent a transformative approach in the pharmacological management of obesity by mimicking endogenous glucagon-like peptide-1, a hormone integral to glucose homeostasis and appetite regulation. These agents enhance insulin secretion, delay gastric emptying, and promote satiety, thereby orchestrating a … Read more